Diabetic Medicine

Cover image for Vol. 31 Issue 5

Editor-in-Chief: Professor Graham A. Hitman, London, UK

Impact Factor: 3.241

ISI Journal Citation Reports © Ranking: 2012: 49/122 (Endocrinology & Metabolism)

Online ISSN: 1464-5491



Author Guidelines


QUICK LINKS

Submission Checklist [optional]
Copyright [req] see section 6 below
OnlineOpen Order see section 6 below
Online Submission [req]
CONSORT Checklist [req for RCTs]
STROBE Checklists (Cohort, Case-control, Cross-sectional) [req for observational studies]
PRISMA Checklist [req for systematic reviews/meta-analyses]
Peer-review Process Map
Contact the Editorial Office

1. ABOUT DIABETIC MEDICINE

Aims & Scope

Diabetic Medicine, the official journal of Diabetes UK, is published monthly in simultaneous print and online editions.

The journal publishes a range of key information on all aspects of diabetes mellitus and issues regularly include original articles, reviews, reports, editorials, comment, news and correspondence. All material is peer-reviewed. The journal seeks to provide a forum for the exchange of information between clinicians and researchers worldwide and all health professionals responsible for the care of patients with diabetes.

Surplus generated from the sale of Diabetic Medicine is used by Diabetes UK to care for, connect with and campaign on behalf of all people affected by and at risk of diabetes.

2. MANUSCRIPT CATEGORIES

Diabetic Medicine invites the following types of submission:

Research articles

Original research articles relevant to diabetes mellitus science and practice are the journal’s primary mode of communication. Clinical science and clinically-relevant basic science papers will be considered. Original articles must include a structured abstract (maximum 250 words), should not exceed 3,000 words of text and should be limited to 30 references. Inclusion of supplementary materials in the form of underlying datasets, multimedia files or accompanying slidesets is encouraged.

Authors of qualitative research articles are advised to contact the Editorial Office for guidance on manuscript length prior to submission.

Manuscripts should adhere to reporting standards. Randomised controlled trials should adhere to the CONSORT Checklist. Observational studies should adhere to the relevant STROBE Checklist. Systematic reviews and meta-analyses should adhere to the PRISMA Checklist. Checklists must be completed and submitted electronically with the manuscript using file designation ‘Supporting Document NOT for Publication’.

For purposes of presentation only, accepted research articles are divided into the following sections:

Care Delivery
Complications
Educational and Psychological Aspects
Epidemiology
Genetics
Health Economics
Metabolism
Pathophysiology
Treatment

Reviews

The journal aims to publish concise, high-quality review articles of recent advances in laboratory or clinical research. Review articles are usually solicited by the Editor-in-Chief but unsolicited reviews are welcome. All will undergo peer-review. Review articles must include an unstructured abstract (maximum 250 words), should not exceed 5,000 words of text and should be limited to 50 references. Use of illustrations and figures is encouraged.

Trial protocols

Diabetic Medicine now welcomes submission of trial protocols. Manuscripts must include a structured abstract (maximum 250 words), should not exceed 3,000 words of text and should be limited to 30 references. Inclusion of supplementary materials in the form of underlying datasets, multimedia files or accompanying slidesets is encouraged. For trial protocols of health care interventions, the last section of the abstract should be Trial Registration: listing the trial registry and the unique identifying number, e.g. Trial Registration: Current Controlled Trials ISRCTN73824458. Please note there should be no space between the letters and numbers of the trial registration number. The trial registers that currently meet all of the ICMJE guidelines can be found at http://www.icmje.org/faq_clinical.html . Publishing your trial protocol in Diabetic Medicine does not commit you to submitting subsequent reports of the study to us, although we do, of course, welcome such submissions.

Short reports

Concise reports of original or important observations, short reports should not exceed 1,500 words and are limited to one figure, one table and 20 references. A structured abstract is required.

Case reports

Case reports submitted after 1 May 2012 will be published online-only in Diabetic Medicine. The abstracts of case reports will continue to be published in the relevant print issue. Case reports remain fully citable and will continue to be indexed by PubMed.

Case reports should describe unusual clinical cases and must carry a new or important message. Cases that present a diagnostic, ethical or management challenge, or that highlight aspects of mechanisms of injury, pharmacology or histopathology are deemed of particular educational value. Descriptions of a series of cases stand a greater chance of being accepted. The Editors reserve the right to ask authors to revise a single case report into a Letter to the Editor.

Case reports should not exceed 1,500 words and are limited to 3 tables and/or 3 figures and 20 references. A structured abstract (maximum 250 words) must be provided using the following sub-headings: Background, Case Report, Discussion. The submission of supplementary materials (additional figures, tables, datasets, multimedia files, etc.) which add value to cases is encouraged.

Letters

Items of correspondence may be in response to issues arising from recently published articles, or short, free-standing pieces expressing an opinion. Letters should be formatted in one continuous section and should not exceed 800 words, 1 figure/table and 10 references. No abstract is required. Please give the name(s) and affiliation(s) of authors at the end of the letter. All letters are subject to peer-review.

Editorials/Commentaries

Editorials and commentaries provide expert opinion to hot topics. Whilst typically commissioned by the Editors, unsolicited submissions are welcome. Editorials and commentaries should not exceed 1,000 words and 10 references. No abstracts are required.

3. SUBMISSION OF MANUSCRIPTS

All submissions must be made online at the Diabetic Medicine ScholarOne Manuscripts site. New users should first create an account. Once a user is logged onto the site, submissions should be made via the Author Centre.

A Submission Checklist is available to help authors comply with the journal style and the submission requirements.

4. PREPARATION OF MANUSCRIPTS

Manuscripts must be written in English.

Manuscript text must be saved in Word (.doc or .docx) or Rich text Format (.rtf). Please do not submit text in PDF format (.pdf).

Figures must be saved as separate figure files.

Abbreviations must be defined when first used in the abstract and in the main text, as well as when first used in table and figure captions.

Manuscripts must be as succinct as possible. Repetition of information or data in different sections of the manuscript must be carefully avoided. Text must comply with the word limits defined in Section 2, and, where appropriate, include:

Title page

The first page of all manuscripts should contain the following information:

1) the title of the paper (maximum 50 words)
2) a running head not exceeding 75 characters
3) names of authors as initial(s) followed by surnames
4) names of the institutions at which the research was conducted, clearly linked to respective authors
5) name and email address of corresponding author
6) manuscript word count
7) a statement of all funding sources
8) any conflicts of interest disclosures (see Section 5)
9) a bulleted novelty statement (maximum 100 words) which describes the novelty of the data presented and their impact on the field (Research Articles, Short Reports and Case Reports only).

Abstracts

Authors submitting research articles and short reports should note that structured abstracts (maximum 250 words) are required. The structured abstract should adopt the format: Aims, Methods, Results, Conclusions.

Structured abstracts for case reports should adopt the format: Background, Case Report, Discussion.

Abstracts should contain no citations to previously published work.

Review articles require abstracts but they need not be structured. Letters do not require abstracts.

Text

This should in general, but not necessarily, be divided into sections with the headings: Introduction, Patients and Methods, Results, Discussion, Funding, Conflicts of Interest, Acknowledgements, References, Tables, Figure Legends.

Tables & figures

Tables and figures should not be inserted in the appropriate place in the text but should be included at the end of the manuscript, each on a separate page.

Tables and figures should be referred to in text as follows: Fig. 1, Figs. 2–4; Table 1, Table 2. Each table and/or figure must have a legend that explains its purpose without reference to the text; legends should include include keys to symbols and indicate the statistical significance of differences. Where a figure has more than one panel, each panel should be labelled in the top left-hand corner using lower case letters in parentheses, i.e., (a), (b), etc., and a brief description of each panel given in the figure legend.

Colour illustrations are welcomed and all colour is published free of charge to the author.

Authors are themselves responsible for obtaining permission to reproduce previously published figures or tables. When an individual is identifiable in a photograph written permission must be obtained (see Section 5 below).

Figure requirements

Figure files should be provided in high resolution .eps format, minimum 800dpi (for graphs and charts) or .tiff format, minimum 300dpi (for photographs or a combination of images and text). Figures with multiple parts (A, B, C) or images should be provided as separate files. Do not copy and paste figure files into the manuscript word document.

If you no longer have the original data to improve/recreate graphs, charts or combination figures to high resolution, please crop the graph area in Microsoft PowerPoint and re-type all text and numbers in the figure. Text should be Arial or Times New Roman in minimum 14pts. Any lines in the figures must be at least 1.5 or 2pts thick. We accept .ppt files.

For more information on file requirements, please refer to http://authorservices.wiley.com/prep_illust.asp.

References

References should be in Vancouver format and appear in the text as consecutive numbers in square brackets, e.g., ‘in our previous reports [1,2] and those of Smith et al. [3–6]’ and should be listed numerically in the reference list at the end of the article.

Format references as below, using standard (Medline) abbreviations for journal titles. If multi-authored, include the first six authors followed by et al.

1. Department of Health. The New NHS: Modern, Dependable. London: The Stationery Office, 1997.

2. Fogari R, Mugellini A, Destro M, Corradi L, Lazzari P, Zoppi A et al. Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial. Diabet Med 2012; 29: 24–31.

3. Eye Care Wales. Screening for Diabetic Retinopathy. March 2009. Available at http://www.wales.nhs.uk/sites3/page.cfm?orgid=562&pid=12776 Last accessed 1 January 2012.

Reporting standards

Manuscripts should adhere to reporting standards. Randomised controlled trials should adhere to the CONSORT Checklist. Observational studies should adhere to the relevant STROBE Checklist. Systematic reviews and meta-analyses should adhere to the PRISMA Checklist. Checklists must be completed and submitted electronically with the manuscript using file designation ‘Supporting Document NOT for Publication’.

Style guide

Diabetic Medicine does not recognise the term 'diabetic' as a noun. Preferred style is ‘people (or person) with diabetes’ or ‘in the group without diabetes’, rather than ‘diabetic people (or person)’ and ‘non-diabetic group’. The terms 'Type 1' and 'Type 2 diabetes mellitus' (abbreviated to Type 1 and Type 2 DM) are preferable to IDDM and NIDDM. 'Men' and 'women' should be used in preference to 'males' and 'females'.

Abbreviations & units

Except for units of measurement, abbreviations are strongly discouraged. Avoid abbreviations in the title of the manuscript and in the Abstract. The spelled-out abbreviation followed by the abbreviation in parentheses should be used on first mention unless the abbreviation is a standard unit of measurement.

SI units must be used throughout except for blood pressure (mmHg) and haemoglobin (g/l). Gas or pressure values should be given as mmHg with kPa in parentheses or vice versa. Where molecular weight is known, the amount of a substance should be expressed in mol or appropriate subunit (mmol). Energy should be expressed in kcal or joules (J). The solidus may be used in a unit as long as it does not have to be employed more than once (e.g. mmol/l is acceptable), but ml/min/kg is not acceptable and should be replaced with ml min-1 kg-1.

HbA1c Measurement

Diabetic Medicine has adopted dual reporting of glycated haemoglobin (HbA1c) measurement. HbA1c measurements must be reported in IFCC units (mmol/mol - no decimal point) in addition to derived NGSP units (% - one decimal). IFCC units should be listed first followed by NGSP units in parentheses. A HbA1c conversion table is available here. NGSP SD’s can be converted directly to IFCC SD’s. To do so the slope of the Master Equation to convert NGSP results to IFCC units must be used. For example: 0.3% SD NGSP = 0.3 X 10.93 = 3.3 mmol/mol SD IFCC (then round to the nearest integer).

5. DECLARATIONS & PUBLICATION ETHICS

Original publication

Submission of a manuscript will be held to imply that it contains original unpublished work and is not being submitted for publication elsewhere at the same time. The author must supply a full statement to the Editor about all submissions and previous reports that might be regarded as redundant or duplicate publication of the same or very similar work. Data that have been published as an abstract of no more than 300 words in a scientific meeting are acceptable; the abstract reference should be quoted under the abstract.

Conflicts of interest

Authors are responsible for disclosing all financial and personal relationships between themselves and others that might be perceived by others as biasing their work. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist.

Ethics

When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 1983. Do not use patients' names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution's or a national research council's guide for, or any national law on, the care and use of laboratory animals was followed. A statement describing explicitly the ethical background to the studies being reported should be included in all manuscripts in the Materials and Methods section. Ethics committee or institutional review board approval should be stated.

Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be published in written descriptions, photographs and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Identifying details should be omitted if they are not essential but patient data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.

Authorship

All persons designated as authors should qualify for authorship and all those who qualify should be listed. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to published article. Authorship credit should be based only on 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published. Conditions 1, 2 and 3 must all be met. Acquisition of funding, the collection of data or general supervision of the research group, by themselves, do not justify authorship. All others who contributed to the work who are not authors should be named in the Acknowledgements section.

Committee on Publication Ethics (COPE)

As a member of the Committee on Publication Ethics (COPE), adherence to these submission criteria is considered essential for publication in Diabetic Medicine; mandatory fields are included in the online submission process to ensure this. If, at a later stage in the submission process or even after publication, a manuscript or authors are found to have disregarded these criteria, it is the duty of the Editor to report this to COPE. COPE may recommend that action be taken, including but not exclusive to, informing the authors' professional regulatory body and/or institution of such a dereliction.

The website for COPE may be accessed at: http://publicationethics.org/

6. ADDITIONAL INFORMATION ON ACCEPTANCE

Copyright

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement

If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:

CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp

For authors choosing OnlineOpen

If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

  • Creative Commons Attribution Non-Commercial License OAA
  • Creative Commons Attribution Non-Commercial -NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.

For RCUK and Wellcome Trust authors click on the links below to preview the terms and conditions of this license:

  • Creative Commons Attribution License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

OnlineOpen

OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive.

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

Note to NIH Grantees

Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, click here.

Proofs

The corresponding author will receive an email alert containing a link to a web site where the proofs can be downloaded as an Acrobat PDF. A working e-mail address must therefore be provided for the corresponding author. In the absence of the corresponding author, please arrange for a colleague to access the e-mail to retrieve the proofs.

Acrobat reader can be downloaded (free of charge) from the following website: http://www.adobe.com/products/acrobat/readstep2.html. This will enable the file to be opened, read and corrected on screen. Further instructions will be sent with the proof.

Please note that you have final responsibility for what is stated in the proofs of your manuscript. Significant textual alterations are unacceptable at proof stage without the written approval of the Editor-in-Chief, and they are likely to result in the delay of publication.

Author Services

Author Services enables authors to track their article—once it has been accepted—through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit Author Services for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.

Accepted Articles

Further to acceptance in Diabetic Medicine, manuscripts are immediately made publicly available online. 'Accepted Articles' have been peer-reviewed and accepted for formal publication, but have not been subject to copyediting, composition or proof correction. The service provides for the earliest possible dissemination of research data following article acceptance. Accepted Articles appear in PDF format only and are given a Digital Object Identifier (DOI), which allows them to be cited and tracked. The DOI remains unique to a given article in perpetuity and can continue to be used to cite and access the article further to print publication. More information about DOIs can be found online at http://www.doi.org/faq.html. Accepted Articles will be indexed in PubMed.

Neither Diabetes UK nor Wiley can be held responsible for errors or consequences arising from the use of information contained in Accepted Articles; nor do the views and opinions expressed necessarily reflect those of Diabetes UK or Wiley.

Early View

Research Articles (Research: Subcategory and Short Report: Subcategory) accepted by Diabetic Medicine are covered by Wiley-Blackwell Publishing’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article.

Offprints

A PDF offprint of the online published article will be provided free of charge to the corresponding author via Author Services. Paper offprints of the printed published article may be ordered online. Please click on the following link, fill in the necessary details and ensure that you type information in all of the required fields: http://offprint.cosprinters.com. If you have queries about offprints please e-mail offprint@cosprinters.com.

SEARCH

SEARCH BY CITATION